丽珠医药(01513)11月4日斥资599.98万元回购16.47万股A股

Core Viewpoint - Lijun Pharmaceutical (01513) announced a share buyback plan, intending to repurchase 164,700 A-shares at a cost of 5.9998 million yuan, scheduled for November 4, 2025 [1] Summary by Category - Company Actions - The company plans to spend 5.9998 million yuan to buy back 164,700 A-shares [1]